Biotech International Ltd (BBIL) on Friday said it would
manufacture 10 types of vaccines including Malaria and COVID-
19 in its upcoming unit in Odisha.
BBIL Chairman and Managing Director Dr Krishna Ella
said this while attending a meeting through digital mode with
Odisha chief secretary A K Tripathy and other state
BBIL is a multi-dimensional biotechnology organisation
specializing in manufacture of vaccines and bio-therapeutics,
The company has taken up the development and
production of new or improved vaccines against severe
Rotavirus Diarrhoea, Malaria, Japanese Encephalitis, Rabies,
Pandemic Influenza and drug resistant Staphylococcus aureus,
In BBIL''s unit at Andharua of Bhubaneswar, the company
would produce 10 types of vaccines including malaria and
COVID-19, he said, adding that the total investment would be
around Rs 300 crore.
Best of the technology will be put in the Odisha unit,
the BBIL chief said.
The chief secretary assured BBIL that the state
government would provide all support for future expansion of
the unit at Andharua in Bhubaneswar.
Tripathy also directed the authorities to start the
ground level construction work within a fortnight and commence
production within the scheduled time.
The chief secretary also asked the BBIL to set up a
''state of art'' biotech incubation center, common facilities
and IT corridor along with the first phase construction of the
The company was also requested to promote the local
Secretary Skill Development and Technical Education
and Chairman & Managing Director IDCO SK Singh said: "Land is
readily available at Biotech Park, Andharua for groundbreaking
works. The building plan as per the design has also been
Principal Secretary Science and Technology S Sadangi
said: "the required statutory clearances and pollution control
board permission has been availed for setting up the unit".